Merck at SCOPE 2027
Mar 1–4, 2027 Orlando, FL ~5k attendees Website
Merck brings 16 presentations to SCOPE 2027 in Orlando. Its sessions cover digital outcome measures, biospecimen tracking, smarter site selection and patient-facing AI for recruitment. One example tracks motor function progression in early Parkinson's disease with composite measures built from sensor data.
| Organization | SCOPE 2027 Attendance |
|---|---|
Merck Rahway, NJ | |
Global pharmaceutical company, known as MSD outside the US and Canada, developing medicines and vaccines. | Panel Mon Mar 1 4:13pm–4:35pm KEYNOTE INTERACTIVE PANEL: SCOPE's 11th Annual Participant Engagement Awards Patient recruitment and engagement Talk Tue Mar 2 11:05am–11:30am Talk Tue Mar 2 11:30am–11:55am Talk Tue Mar 2 11:30am–11:55am Talk Tue Mar 2 3:05pm–3:30pm Panel Tue Mar 2 3:05pm–3:55pm Talk Tue Mar 2 3:05pm–3:30pm Talk Tue Mar 2 4:45pm–5:10pm Talk Tue Mar 2 4:45pm–5:10pm Talk Wed Mar 3 9:20am–9:35am Panel Wed Mar 3 9:25am–9:50am Talk Wed Mar 3 9:25am–9:50am Talk Wed Mar 3 11:40am–12:05pm Panel Wed Mar 3 2:35pm–3:00pm Panel Thu Mar 4 8:35am–9:00am Shared Challenges, Shared Solutions: Advancing Biospecimen Management across the Clinical Trial Ecosystem Biospecimen strategy and operations Panel Thu Mar 4 9:25am–9:50am Driving Clinical Trial Efficiency with Digital Measures Digital measures and eClinical technology |
Instantly find 20 buyers from Merck
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction